中国实用外科杂志2017，Vol.37Issue(7)：744-748,5.DOI:10.19538/j.cjps.issn1005-2208.2017.07.09
新辅助治疗用于局部进展期胰腺癌临床评价
Application and evaluation of neoadjuvant therapy in locally advanced pancreatic carcinoma
张太平 1曹喆 1赵玉沛1
作者信息
- 1. 中国医学科学院北京协和医院基本外科,北京100730
- 折叠
摘要
Abstract
Radical resection is the effective means to prolong survival time of patients with pancreatic carcinoma. However, 40% of the patients are diagnosed with locally advanced pancreatic carcinoma in the first clinic. Individualized neoadjuvant treatment is expected to bring the stage-down of locally advanced pancreatic carcinoma,in order to gain the chance of radical excision. But the specific treatment is still controversial. Neoadjuvant chemotherapy followed by sequential chemoradiotherapy is the most common strategy in the neoadjuvant therapy. Gemcitabine plus nab-Paclitaxel and FOLFIRINOX are expected to be the best chemotherapy regimens.关键词
局部进展期胰腺癌/新辅助治疗Key words
locally advanced pancreatic carcinoma/neoadjuvant therapy分类
医药卫生引用本文复制引用
张太平,曹喆,赵玉沛..新辅助治疗用于局部进展期胰腺癌临床评价[J].中国实用外科杂志,2017,37(7):744-748,5.
